A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis

Clinical trial NCT04800315 · COMPLETED

Trial details

NCT number: NCT04800315
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dermatitis, Atopic Eczema

Start date: 2021-05-14
Primary completion: 2022-07-20
Enrollment: 221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.